Literature DB >> 24966503

Assessment of Antepartum Fetal Growth by Customized "GROW" Curves Versus Noncustomized Growth Curves in Correlation with Neonatal Growth Pattern.

Shamim Khandaker1.   

Abstract

OBJECTIVE: To study the antepartum fetal growth between customized "GROW" curves and noncustomized growth curves with neonatal growth pattern.
METHOD: Fetal growth scans are performed between 30 and 35 weeks to singleton mother. Estimated fetal weights (EFWs) were determined using ultrasound variables (biparietal diameter, head circumference, abdominal circumference, and femur length). This EFW is plotted on SONOCARE software [noncustomized growth curves developed by Medialogic solutions (P) Ltd., Chennai, India] and customized "GROW" curves to determine the type of antenatal fetal growth as AGA, small for gestational age (SGA), or large for gestational age (LGA). The fetuses were followed longitudinally till birth, and the newborns' growth patterns were determined according to birth weight at the gestational age of delivery (<10th percentile for gestational age as SGA and >90th percentile as LGA) and compared to antenatal prediction of fetal growth patterns determined by noncustomized growth curves and customized "GROW" curves.
RESULTS: According to noncustomized growth curve at antenatal period, 93 % fetuses are AGA; 5.6 % are LGA, and 1 % are SGA. According to customized GROW curves, when the same EFW is plotted on GROW curves, 83 % are found to be AGA, 6.8 % LGA, and 10 % SGA. At postnatal period, according to newborn growth curve, 87.8 % are AGA, 8.8 % LGA, 3.4 % SGA. Sensitivity of customized "GROW" curves is more than that of noncustomized growth curves (45.45 vs. 18.18 %) for detection of SGA fetus.
CONCLUSION: Antenatal predictions of SGA baby by ultrasonography can be almost doubled with customized "GROW" curves than noncustomized growth curves. Customized GROW curves also better predict perinatal morbidities like neonatal jaundice and NICU admission. Antenatal serial fetal growth monitoring should be done with customized GROW curves.

Entities:  

Keywords:  Customized growth curves; Fetal growth

Year:  2014        PMID: 24966503      PMCID: PMC4061327          DOI: 10.1007/s13224-014-0514-7

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  4 in total

Review 1.  Prediction of the small for gestational age infant: which ultrasonic measurement is best?

Authors:  T C Chang; S C Robson; R J Boys; J A Spencer
Journal:  Obstet Gynecol       Date:  1992-12       Impact factor: 7.661

2.  Excess mortality and morbidity among small-for-gestational-age premature infants: a population-based study.

Authors:  Rivka H Regev; Ayala Lusky; Tzipora Dolfin; Ita Litmanovitz; Shmuel Arnon; Brian Reichman
Journal:  J Pediatr       Date:  2003-08       Impact factor: 4.406

3.  Adverse pregnancy outcome and association with small for gestational age birthweight by customized and population-based percentiles.

Authors:  Jason Gardosi; Andre Francis
Journal:  Am J Obstet Gynecol       Date:  2009-07       Impact factor: 8.661

4.  The value of customised centiles in assessing perinatal mortality risk associated with parity and maternal size.

Authors:  J Gardosi; B Clausson; A Francis
Journal:  BJOG       Date:  2009-06-17       Impact factor: 6.531

  4 in total
  2 in total

1.  Gestational growth trajectories derived from a dynamic fetal-placental scaling law.

Authors:  Daniel Baller; Diana M Thomas; Kevin Cummiskey; Carl Bredlau; Nadav Schwartz; Kelly Orzechowski; Richard C Miller; Anthony Odibo; Ruchit Shah; Carolyn M Salafia
Journal:  J R Soc Interface       Date:  2019-10-30       Impact factor: 4.118

2.  Prediction of adverse perinatal outcome by fetal biometry: comparison of customized and population-based standards.

Authors:  D Kabiri; R Romero; D W Gudicha; E Hernandez-Andrade; P Pacora; N Benshalom-Tirosh; D Tirosh; L Yeo; O Erez; S S Hassan; A L Tarca
Journal:  Ultrasound Obstet Gynecol       Date:  2020-02       Impact factor: 7.299

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.